Latest News - CRSToday

Friday, October 20, 2017 | Cornea, Medical Studies

Newcastle Scientists Eye-Up Cornea 'Breakthrough'

Artificial corneas have been grown using a new method described as "revolutionary." Scientists at Newcastle University have developed a process they say makes them fit better and offer bette…

Read the full story

Friday, October 20, 2017 | Glaucoma, Partnerships, Nicox

Nicox Enters Research Collaboration with Re-Vana Therapeutics to Explore Drug Delivery Platform for the Reduction of IOP

Nicox SA and Re-Vana Therapeutics announced that they have entered into a research collaboration to explore combining Nicox’s next generation of stand-alone nitric oxide (NO)-donors with Re-Vana…

Read the full story

Friday, October 20, 2017 | Dry Eye

Aurinia to Expand Renal Franchise with Novel Indications and Launches Development Program for Treatment of Dry Eye Syndrome

Aurinia Pharmaceuticals announced plans to expand its voclosoprin renal franchise to include focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD). Additionally, Aurinia announced…

Read the full story

Thursday, October 19, 2017 | Partnerships

Healthe and Corning Announce Collaboration on Technology to Help Protect Against Digital Device Blue Light Exposure

Healthe and Corning announced a collaboration to develop and introduce Eyesafe technology made with "Accessory Glass 2" by Corning. When integrated with Corning Glass, Eyesafe technology sel…

Read the full story

Thursday, October 19, 2017 | Fundraisers, Ziemer

Join Ziemer for Drinks at AAO and Support Hurricane Relief

Ziemer will make a donation for hurricane relief efforts for every hurricane cocktail served from the Ziemer Bar at the American Academy of Ophthalmology Meeting, November 11-14 at the Ernest N. Moria…

Read the full story

Thursday, October 19, 2017 | Dry Eye, Product Releases, Imprimis Pharmaceuticals

Imprimis Pharmaceuticals to Offer Compounded Cyclosporine

Imprimis Pharmaceuticals announced it is making compounded cyclosporine-based formulations for dry eye disease. The formulations, which will be packaged in a preservative-free bottle, are patent-pendi…

Read the full story

Wednesday, October 18, 2017 | Medical Studies

Ophthalmologists Spend Substantial Time on EHR Use

Ophthalmologists spent more than a quarter of their time with patients on electronic health records (EHRs), despite already having limited time overall to spend with patients, according to a single-ce…

Read the full story

Tuesday, October 17, 2017 | Glaucoma

iSTAR Medical Completes Enrollment of First-in-Human MIGS Trial

iSTAR Medical announced the completion of enrollment in their first-in-human microinvasive glaucoma surgery (MIGS) trial for the MINIject device. The first-in-human trial is a prospective, ope…

Read the full story

Tuesday, October 17, 2017 | Management/Leadership, Foundation Fighting Blindness

Benjamin Yerxa Named Foundation Fighting Blindness CEO

The Foundation Fighting Blindness (FFB) announced that it has selected Benjamin Yerxa, a biotechnology and drug development executive, as its Chief Executive Officer, effective immediately. The Fou…

Read the full story

Monday, October 16, 2017 | FDA Approval/Clearance, Product Releases, Topcon Medical Systems

Topcon’s PASCAL Synthesis TwinStar Laser Receives FDA 510(k) Clearance

Topcon Medical Systems announced that its PASCAL Synthesis TwinStar laser has received FDA 510(k) clearance. The Synthesis TwinStar expands the PASCAL line of laser photocoagulators offering the abili…

Read the full story

Monday, October 16, 2017 | Corporate Lawsuits, Allergan

Allergan Shares Slip As Judge Invalidates Patent on Top Selling Eye Drop

A federal judge struck down patents protecting one of Allergan’s top-selling drugs, sending shares in the company down nearly 5 percent, according to a report in the Financial Times. The Texa…

Read the full story

Monday, October 16, 2017 | Medical Studies, STAAR Surgical

Staar Surgical Survey Examines How Americans Prioritize Eye Care

The majority of Americans prioritize eating out over spending money on eyecare, including appointments with eye doctors and prescription glasses, according to a new survey conducted by Staar Surgical,…

Read the full story

Monday, October 16, 2017 | Medical Studies

Retinal Pharmaceutical and Biologics Market to Grow to $13.9 Billion by 2022

The retinal pharmaceuticals and biologics market is the biggest market segment in ophthalmology, and it keeps growing as the companies marketing Eylea (Regeneron, Bayer, and Santen) and Lucentis (Roch…

Read the full story

Monday, October 16, 2017 | Acquisitions/Mergers, Eye Care Leaders

Eye Care Leaders Acquires iMedicWare to Launch Fully Integrated Technology Platform for Ophthalmology

Eye Care Leaders (ECL) announced the acquisition of iMedicWare, a provider of integrated EHR, practice management, ambulatory surgery center software, and optical solutions designed exclusively for ey…

Read the full story

Monday, October 16, 2017 | Product Releases, Bausch+Lomb

Bausch + Lomb Introduces Envista MX60E IOL

Bausch + Lomb announced the introduction of the enVista MX60E with StableFlex technology, the company's next-generation hydrophobic acrylic lens. The enVista MX60E features AccuSet haptics, whi…

Read the full story
Load More